Evidence map›Paper›PMID 40329450›Full record

ArticleGlobal public health2025

Organoids at the forefront of global health: accelerated research and ethical implications in the cases of Zika and COVID-19.

Amy Hinterberger, Aleksandra Stelmach

Abstract read
In one paragraph

Article in Global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amy HinterbergerDepartment of Bioethics and Humanities, University of Washington, Seattle, WA, USA.
Aleksandra StelmachDepartment of Global Health and Social Medicine, King's College London, London, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Bioengineering technologies are increasingly important in global health research, yet their applications beyond vaccines and diagnostics remain underexplored. Our paper examines the role of organoids - advanced stem cell technologies used to model human organs, such as lungs and brains - in the context of infectious disease research. Organoids became crucial during the Zika and COVID-19 outbreaks. These new model systems enabled rapid insights into pathogen behaviour. We analyse how the urgency of Zika and Covid-19 accelerated organoid research, tracing its rise and subsequent slowdown. Our investigation reveals that while organoid technologies experienced a burst of activity during these emergencies, their momentum has waned, with ongoing research predominantly focusing on diseases prevalent in the Global North. We argue that the uneven acceleration and subsequent deceleration of organoid research underscores a critical need for equitable integration of bioengineering in global health priorities, particularly in the context of pandemic preparedness. Our findings advocate for a balanced and inclusive strategy to enhance pandemic preparedness and address global health disparities effectively.

Indexed as

Biomedical ResearchCOVID-19Global HealthOrganoidsZika Virus InfectionHumansPandemicsSARS-CoV-2ethicsglobal healthOrganoids

Identifiers

PMID40329450
PMCPMC12306667

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.